NSE: APOLLOHOSP | BSE: 508869

Mid-range Performer

Download real time

8957.00 -31.00 (-0.34%)

New 52W High today

271.3K NSE+BSE Volume

NSE 31 Jul, 2026 3:31 PM (IST)

128,788

Market Cap

Market Leader

Beta 1Year

Very Low volatility

Dividend

Apollo Hospitals has an upcoming dividend of ₹10.000 per share due on 14 Aug 2026 See details

Apollo Hospitals Enterprise Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for APOLLOHOSP, BSE:508869 Apollo Hospitals Enterprise Ltd.

Search Inside the pdf :

Apollo Hospitals Enterprise Ltd.

23 Jun 2026

8957.00

-0.34%

APOLLO HOSPITAL

Buy: Apollo Hospitals Enterpris...

Target

Geojit BNP Paribas

*over or under performance to benchmark index Apollo Hospitals delivered strong revenue growth driven by robust operational momentum across healthcare services, expanding diagnostics footprint, and improving digital platform efficiency. The company is well-positioned with its aggressive bed expansion pipeline, strategic demerger of Apollo HealthCo to unlock value, and imminent digital health platform breakeven. Management's guidance on sustained mid-teen hospital growth, margin expansion in established units, and digital profitability reinforces...

Apollo Hospitals has gained 28.91% in the last 6 Months

Apollo Hospitals Enterprise Ltd.

22 May 2026

8957.00

-0.34%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Direct

expansion despite losses at the new hospitals- Revenues grew ~18% YoY to 6605.5 crore, driven by growth across segments. EBITDA grew 31.3% to 1011 crore and EBITDA Margins improved 154 bps to 15.3%, driven by improved profitability at AHLL (Diagnostic and Retail Healthcare) and HealthCo (Pharmacy). Healthcare services division (Hospitals) revenues grew ~16% YoY to 3268 crore on the back of growth in Inpatient Volume (up 7%) and 4% increase in Price & 5% increase of case mix. EBITDA growth...

Apollo Hospitals Enterprise Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

22 May 2026

8957.00

-0.34%

Apollo Hospitals Enterprise (APHS IN) Q4FY26 Result Update Strong growth across segments BUY

Buy: Apollo Hospitals Enterpris...

Target

Prabhudas Lilladhar

FY27 growth capex of ~INR19.8bn for ~1,000 bed additions Apollo Hospitals Enterprise (APHS) reported consolidated EBITDA of INR10.1bn (up 31% YoY), which was 5% above our estimates. Adjusted for 24x7 losses and ESOPs cost (~INR959mn), EBITDA was Rs11.1bn, up 19% YoY. The stake sale in HealthCo to Advent and merger with Keimed are positive moves toward an integrated pharmacy and digital health platform, with Apollo HealthCo scaling up well and its digital business on track for EBITDA breakeven in coming quarters. The management guidance of INR16.517.5bn EBITDA of the merged entity by Q4FY27 (exit run-rate) provides comfort. Further, mgmt. has also announced the demerger of its Omnichannel Pharmacy...

Apollo Hospitals Enterprise Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

13 Mar 2026

8957.00

-0.34%

Building India’s Integrated Healthcare Ecosystem

Buy: Apollo Hospitals Enterpris...

FundsIndia

Bed occupancy improved from ~55% in FY21 to ~68% in FY25. Strong demand for high-acuity CONGO-T specialties. Average revenue per inpatient rising with better case mix.

Number of FII/FPI investors increased from 1690 to 1762 in Jun 2026 qtr.

Apollo Hospitals Enterprise Ltd.

12 Feb 2026

8957.00

-0.34%

Apollo Hospitals

Buy: Apollo Hospitals Enterpris...

Target

ICICI Direct

Q3FY26 Results- well-rounded growth with continued margin expansion- Revenues grew ~17% YoY to 6477 crore, driven by growth across segments. EBITDA grew 27% to 965 crore and EBITDA Margins improved 112 bps to 14.9%, driven by improved profitability at AHLL (Diagnostic and Retail Healthcare) and Healthcare Services (Hospitals). Healthcare services division (Hospitals) revenues grew 14% YoY to 3183 crore on the back of growth in Inpatient Volume (up 4%) and 3% increase in Price & 7%...

Apollo Hospitals Enterprise Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

11 Feb 2026

8957.00

-0.34%

Hospital optimization, HealthCo traction drive beat

Buy: Apollo Hospitals Enterpris...

Motilal Oswal

Apollo Hospitals Enterprises (APHS) delivered a strong beat on revenue/EBITDA/PAT (6%/6%/13%) in 3QFY26. The performance was largely driven by both hospitals and Healthco (digital health and offline pharmacy).

Apollo Hospitals Enterprise Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

21 Jan 2026

8957.00

-0.34%

Hospital engine strong; HealthCo inflection in sight

Buy: Apollo Hospitals Enterpris...

Motilal Oswal

APHS has implemented efforts to gear up for the next phase of growth in the hospital segment through: a sustained shift toward higher-complex case mix and a disciplined greenfield/brownfield expansion plan, with 45% (~3,660) beds to be added over the next five years in a phased manner.

Apollo Hospitals has gained 28.91% in the last 6 Months

Apollo Hospitals Enterprise Ltd.

19 Dec 2025

8957.00

-0.34%

APOLLO HOSPITAL

Buy: Apollo Hospitals Enterpris...

Recommendation Target

Geojit BNP Paribas

The Healthcare Services segment logged a 10.2% YoY revenue growth to Rs. 3,217cr, primarily fuelled by an increase in the insurance and cash patients, which accounted for 86% of the inpatient hospital revenue. Notably, the average revenue...